PCR is more sensitive and specific than standard urine culture for detection of uropathogens [1,2].
PCR identifies 36% more pathogens in patients with suspected UTI than standard urine culture [1].
Turn-around-time for PCR is ~43 hours faster than standard urine culture [3].
Polymicrobial infections are common – seen in 25-50% of UTIs, depending on the patient cohort [1,4].
An additional 12% of patients have polymicrobial infections detected by PCR that are missed on standard urine culture [1].
Antibiotic resistance gene detection only evaluates genotype, while molecular antibiotic sensitivity testing evaluates organism phenotype. Antibiotic resistance genes are not enough – there is a 40% discordance rate between antibiotic resistance genes alone vs. molecular antibiotic sensitivity [5].
PCR testing with molecular antibiotic sensitivity has been retrospectively evaluated and showed patients who had PCR testing with molecular antibiotic sensitivity had 13% lower outpatient ER visits and 76% lower inpatient admissions [6]. An additional retrospective review of PCR with molecular antibiotic sensitivity testing found a 13% decreased risk of ER or hospitalization in a cohort of 66,383 primary care patients [7].
1. Wojno KJ, Baunoch D, Luke N, et al. Multiplex PCR Based Urinary Tract Infection (UTI) Analysis Compared to Traditional Urine Culture in Identifying Significant Pathogens in Symptomatic Patients. Urology. 2020;136:119-26.
2. van der Zee A, Roorda L, Bosman G, Ossewaarde JM. Molecular Diagnosis of Urinary Tract Infections by Semi-Quantitative Detection of Uropathogens in a Routine Clinical Hospital Setting. PLoS ONE. 2016;11(3): e0150755. doi:10.1371/journal.pone.0150755
3. Lehmann LE, Hauser S, Malinka T, et al. Rapid qualitative urinary tract infection pathogen identification by SeptiFast real-time PCR. PLoS One. 2011;6(2):e17146.
4. Vollstedt A, Baunoch D, Wojno KJ, Luke N, Cline K, et al. (2020) Multisite Prospective Comparison of Multiplex Polymerase Chain Reaction Testing with Urine Culture for Diagnosis of Urinary Tract Infections in Symptomatic Patients. J Sur urology: JSU-102. DOI: 10.29011/ JSU-102.100002
5. Baunoch D, Luke N, Wang D, Vollstedt A, Zhao X, Ko DSC, Huang S, Cacdac P, Sirls LT. Concordance Between Antibiotic Resistance Genes and Susceptibility in Symptomatic Urinary Tract Infections. Infect Drug Resist. 2021 Aug 19;14:3275-3286. doi: 10.2147/IDR.S323095. PMID: 34447256; PMCID: PMC8382965.
6. Ashok A, Ko D, Lukacz E, et al. PD32-09: Comparison of Guidance UTI and standard urine culture for rates of sepsis, hospitalization and other adverse outcomes in complicated urinary tract infections. J Urol. 2022;207(No. 5S).
7. Annemarie D, David B, Kelly R, Natalie L, Meghan C, et al. Utilization of M-PCR and P-AST for Diagnosis and Management of Urinary Tract Infections in Home-Based Primary Care. JOJ Urology & Nephrology, 2020; 7(2): 555707. DOI: 10.19080/JOJUN.2020.07.555707
Phone: 913.624.9005 | Fax: 913.261.9117 | 14215 Metcalf, Overland Park, Kansas 66223 | clientservices@mokanlabs.com
Copyright © 2023 Mokan Labs, LLC - All Rights Reserved.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.